NUMD
Nu-Med Plus, Inc.
Price Chart
Latest Quote
$0.01
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 190 |
Stock Information
| Shares Outstanding | 83.55M |
| Total Debt | $222K |
| Cash Equivalents | $4K |
| Net Income | $-52K |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $794K |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.01M |
| Income | $-52K |
| Book/sh | $-0.00 |
| Cash/sh | $0.00 |
| Employees | 2 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.02 |
Returns & Margins
| ROA | -439.12% |
Ownership
| Insider Ownership | 45.04% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -3.17 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.02 |
| ATR | 0.0001 |
| Shares Float | 45.92M |
| Volatility | -2.39 |
| Rel Volume | 0.03 |
Performance History
| Week | -6.86% |
| Month | -6.86% |
| Quarter | -13.64% |
| 6 Months | -48.43% |
| YTD | -33.10% |
| Year | -79.79% |
| 3 Years | -35.37% |
| 5 Years | -93.21% |
| 10 Years | -97.63% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-19 | $0.01 | 190 |
| 2026-06-18 | $0.01 | 0 |
| 2026-06-17 | $0.01 | 190 |
| 2026-06-16 | $0.01 | 0 |
| 2026-06-15 | $0.01 | 2,070 |
| 2026-06-12 | $0.01 | 140,100 |
| 2026-06-11 | $0.01 | 0 |
| 2026-06-10 | $0.01 | 0 |
| 2026-06-09 | $0.01 | 0 |
| 2026-06-08 | $0.01 | 0 |
| 2026-06-05 | $0.01 | 0 |
| 2026-06-04 | $0.01 | 0 |
| 2026-06-03 | $0.01 | 0 |
| 2026-06-02 | $0.01 | 0 |
| 2026-06-01 | $0.01 | 0 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 0 |
| 2026-05-27 | $0.01 | 0 |
| 2026-05-26 | $0.01 | 0 |
| 2026-05-22 | $0.01 | 0 |
| 2026-05-21 | $0.01 | 0 |
| 2026-05-20 | $0.01 | 0 |
| 2026-05-19 | $0.01 | 0 |
About Nu-Med Plus, Inc.
Nu-Med Plus, Inc., a medical device company, engages in the design, innovation, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers. It is also involved in the development of a mobile rechargeable device to deliver nitric oxide gas; and a nitric oxide system that can be used for research applications, as well as a mobile/portable rechargeable device to deliver inhaled nitric oxide gas. Nu-Med Plus, Inc. was incorporated in 2011 and is based in Port Jefferson, New York.
đ° Latest News
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $5,014 | $5,000 | $1,000 | $0 |
| Total Expenses | $63,331 | $120,526 | $182,167 | $839,445 |
| Rent Expense Supplemental | $300 | $12,900 | $12,971 | $23,040 |
| Net Non Operating Interest Income Expense | $-5,014 | $-5,000 | $-1,000 | $0 |
| Interest Expense Non Operating | $5,014 | $5,000 | $1,000 | $0 |
| Operating Expense | $63,331 | $120,526 | $182,167 | $839,445 |
| General And Administrative Expense | $63,331 | $120,526 | $179,900 | $830,080 |
| Other Income Expense | - | - | $53,000 | $9,384 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Net Interest Income | $-5,014 | $-5,000 | $-1,000 | $0 |
| Normalized Income | $-68,345 | $-125,526 | $-183,167 | $-839,445 |
| Net Income From Continuing And Discontinued Operation | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Total Operating Income As Reported | $-63,331 | $-120,526 | $-182,167 | $-839,445 |
| Net Income Common Stockholders | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Net Income | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Net Income Including Noncontrolling Interests | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Net Income Continuous Operations | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Pretax Income | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Operating Income | $-63,331 | $-120,526 | $-182,167 | $-839,445 |
| Special Income Charges | - | $0 | $53,000 | $9,384 |
| Depreciation Amortization Depletion Income Statement | - | $0 | $2,267 | $9,365 |
| Depreciation And Amortization In Income Statement | - | $0 | $2,267 | $9,365 |
| Depreciation Income Statement | - | $0 | $2,267 | $9,365 |
| Per Share | ||||
| Diluted EPS | $0.00 | $0.00 | $-0.00 | $-0.01 |
| Basic EPS | $0.00 | $0.00 | $-0.00 | $-0.01 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-63,331 | $-120,526 | $-171,678 | $-818,069 |
| EBITDA (Bullshit earnings) | $-63,331 | $-120,526 | $-118,678 | $-808,685 |
| EBIT | $-63,331 | $-120,526 | $-129,167 | $-830,061 |
| Diluted Average Shares | $83,548,469 | $81,673,948 | $79,951,209 | $73,374,113 |
| Basic Average Shares | $83,548,469 | $81,673,948 | $79,951,209 | $73,374,113 |
| Diluted NI Availto Com Stockholders | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Selling General And Administration | $63,331 | $120,526 | $179,900 | $830,080 |
| Other Gand A | $63,031 | $65,826 | $142,834 | $539,582 |
| Rent And Landing Fees | $300 | $12,900 | $12,971 | $23,040 |
| Salaries And Wages | $0 | $41,800 | $24,095 | $267,458 |
| Total Unusual Items | - | $0 | $53,000 | $9,384 |
| Total Unusual Items Excluding Goodwill | - | $0 | $53,000 | $9,384 |
| Reconciled Depreciation | - | $0 | $10,489 | $21,376 |
| Gain On Sale Of Ppe | - | $0 | $3,000 | $0 |
| Other Special Charges | - | - | $-50,000 | $-9,384 |
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-215,096 | $-146,751 | $-63,025 | $-132,358 |
| Total Assets | $9,373 | $13,456 | $79,545 | $22,163 |
| Total Non Current Assets | $0 | $0 | $0 | $10,488 |
| Current Assets | $9,373 | $13,456 | $79,545 | $11,675 |
| Prepaid Assets | $7,000 | $6,650 | $6,350 | $0 |
| Cash Cash Equivalents And Short Term Investments | $2,373 | $6,806 | $73,195 | $11,675 |
| Cash And Cash Equivalents | $2,373 | $6,806 | $73,195 | $11,675 |
| Cash Financial | $2,373 | $6,806 | $73,195 | $11,675 |
| Debt | ||||
| Net Debt | $97,627 | $93,194 | $26,805 | - |
| Total Debt | $100,000 | $100,000 | $100,000 | $8,222 |
| Current Debt And Capital Lease Obligation | $100,000 | $100,000 | $100,000 | $8,222 |
| Current Debt | $100,000 | $100,000 | $100,000 | - |
| Other Current Borrowings | $100,000 | $100,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $224,469 | $160,207 | $142,570 | $154,521 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $224,469 | $160,207 | $142,570 | $154,521 |
| Payables And Accrued Expenses | $124,469 | $60,207 | $42,570 | $146,299 |
| Payables | $109,750 | $54,207 | $41,570 | $53,744 |
| Accounts Payable | $109,750 | $54,207 | $41,570 | $53,744 |
| Current Notes Payable | - | $100,000 | $100,000 | $0 |
| Equity | ||||
| Common Stock Equity | $-215,096 | $-146,751 | $-63,025 | $-132,358 |
| Total Equity Gross Minority Interest | $-215,096 | $-146,751 | $-63,025 | $-132,358 |
| Stockholders Equity | $-215,096 | $-146,751 | $-63,025 | $-132,358 |
| Retained Earnings | $-9,893,332 | $-9,824,987 | $-9,699,461 | $-9,569,294 |
| Other | ||||
| Ordinary Shares Number | $83,548,469 | $83,548,469 | $81,348,469 | $79,348,469 |
| Share Issued | $83,548,469 | $83,548,469 | $81,348,469 | $79,348,469 |
| Tangible Book Value | $-215,096 | $-146,751 | $-63,025 | $-132,358 |
| Invested Capital | $-115,096 | $-46,751 | $36,975 | $-132,358 |
| Working Capital | $-215,096 | $-146,751 | $-63,025 | $-142,846 |
| Total Capitalization | $-215,096 | $-146,751 | $-63,025 | $-132,358 |
| Additional Paid In Capital | $9,594,687 | $9,594,687 | $9,555,087 | $9,357,587 |
| Capital Stock | $83,549 | $83,549 | $81,349 | $79,349 |
| Common Stock | $83,549 | $83,549 | $81,349 | $79,349 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $14,719 | $6,000 | $1,000 | $92,555 |
| Net PPE | - | $0 | $0 | $10,488 |
| Accumulated Depreciation | - | $-90,368 | $-90,368 | $-88,102 |
| Gross PPE | - | $90,368 | $90,368 | $98,590 |
| Machinery Furniture Equipment | - | $90,368 | $90,368 | $90,368 |
| Capital Lease Obligations | - | - | $0 | $8,222 |
| Current Capital Lease Obligation | - | - | $0 | $8,222 |
| Dueto Related Parties Current | - | - | - | $26,000 |
| Other Properties | - | - | - | $8,222 |
| Buildings And Improvements | - | - | - | $8,222 |
| Properties | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,433 | $-66,389 | $-38,480 | $-206,831 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,433 | $-66,389 | $-38,480 | $-206,831 |
| Cash Flow From Continuing Operating Activities | $-4,433 | $-66,389 | $-38,480 | $-206,831 |
| Operating Gains Losses | - | - | $-50,000 | $-9,384 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $0 | $0 | $100,000 | $30,000 |
| Cash Flow From Continuing Financing Activities | - | $0 | $100,000 | $30,000 |
| Issuance Of Capital Stock | - | - | $0 | $30,000 |
| Net Common Stock Issuance | - | - | $0 | $30,000 |
| Common Stock Issuance | - | - | $0 | $30,000 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $2,373 | $6,806 | $73,195 | $11,675 |
| Beginning Cash Position | $6,806 | $73,195 | $11,675 | $188,506 |
| Changes In Cash | $-4,433 | $-66,389 | $61,520 | $-176,831 |
| Change In Working Capital | $63,912 | $17,337 | $96,198 | $411,238 |
| Change In Payables And Accrued Expense | $64,262 | $17,637 | $110,770 | $74,232 |
| Change In Accrued Expense | $8,719 | $5,000 | $114,945 | $66,536 |
| Change In Payable | $55,543 | $12,637 | $-4,175 | $7,696 |
| Change In Account Payable | $34,951 | $897 | $-12,553 | $27,696 |
| Change In Prepaid Assets | $-350 | $-300 | $-6,350 | $349,017 |
| Stock Based Compensation | $0 | $41,800 | $35,000 | $200,000 |
| Net Income From Continuing Operations | $-68,345 | $-125,526 | $-130,167 | $-830,061 |
| Issuance Of Debt | - | $0 | $100,000 | $0 |
| Net Issuance Payments Of Debt | - | $0 | $100,000 | $0 |
| Net Long Term Debt Issuance | - | $0 | $100,000 | $0 |
| Long Term Debt Issuance | - | $0 | $100,000 | $0 |
| Change In Other Current Liabilities | - | $0 | $-8,222 | $-12,011 |
| Depreciation Amortization Depletion | - | $0 | $10,489 | $21,376 |
| Depreciation And Amortization | - | $0 | $10,489 | $21,376 |
| Depreciation | - | $0 | $10,489 | $21,376 |